GLB1 and rheumatoid arthritis: Although dasatinib treatment did not significantly affect SA-β-gal activity in either RA- or RA-risk LN fibroblasts, there was a pronounced decrease in the expression level of GLB1, the gene encoding SA-β-gal (Fig. 4B).